February 2014 - Volume 44 - Issue 2
pp: 6-72
Subscribe to eTOC

EDITORIAL

LETTERS

DRUG NEWS

DRUG NEWS

Nursing . 44(2):10-11, February 2014.

Unique extended-release opioid approved...new drug halts hepatitis C virus reproduction...edoxaban compares well to warfarin...common sodium-containing drugs raise risks for cardiac patients...prenatal glucocorticoid exposure may impair brain development...new treatment for rare thyroid cancer

TIME CRITICAL

INFOBYTES

LEGAL MATTERS

RESEARCH CORNER

INSPIRING CHANGE

CLINICAL ROUNDS

STUDENT VOICES

CLINICAL QUERIES

I. V. ROUNDS

MEDICATION ERRORS


Fighting frailty in older patients

Hislop, Joyce O.

Nursing . 44(2):64-66, February 2014.

Frailty—the loss of function, strength, and physiologic reserve—isn't an inevitable part of aging. Help your patients fight back against this debilitating condition by assessing them for frailty and intervening to reduce their risk of adverse outcomes, such as falls and fractures, hospitalizations, and increased healthcare costs.

CE Connection

Non-small cell lung cancer: Recent advances

Held-Warmkessel, Jeanne; Schiech, Linda

Nursing . 44(2):32-42, February 2014.

Lung cancer is the deadliest form of cancer, and non-small cell lung cancer is the most common lung cancer type. This comprehensive article discusses risk factors, diagnostic testing, new staging descriptions, surgical and nonsurgical treatments, and evidence-based nursing interventions for patients as they progress through diagnosis and treatment.

New drugs 2014, part 1

Hussar, Daniel A.

Nursing . 44(2):44-54, February 2014.

Be prepared to administer and teach patients about 14 recently approved drugs, including the first in a new class of antidiabetic agents, an anticoagulant that's proven superior to warfarin for certain indications, and new antineoplastic drugs indicated for multiple myeloma, unresectable or metastatic melanoma, and thyroid cancer.

SHARING

PROFESSIONAL GROWTH